Cargando…

A two-microRNA signature predicts the progression of male thyroid cancer

In various cancers, microRNAs (miRNAs) are abnormally expressed, including thyroid cancer (TC). In recent years, the incidence of TC has increased annually around the world. Compared with female patients, male TC patients are more likely to have a postoperative recurrence and lymph node metastasis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bingyang, Shi, Haihong, Qiu, Weigang, Wu, Xinquan, Li, Liqiong, Wu, Wenyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439266/
https://www.ncbi.nlm.nih.gov/pubmed/34595349
http://dx.doi.org/10.1515/biol-2021-0099
_version_ 1783752504846057472
author Liu, Bingyang
Shi, Haihong
Qiu, Weigang
Wu, Xinquan
Li, Liqiong
Wu, Wenyi
author_facet Liu, Bingyang
Shi, Haihong
Qiu, Weigang
Wu, Xinquan
Li, Liqiong
Wu, Wenyi
author_sort Liu, Bingyang
collection PubMed
description In various cancers, microRNAs (miRNAs) are abnormally expressed, including thyroid cancer (TC). In recent years, the incidence of TC has increased annually around the world. Compared with female patients, male TC patients are more likely to have a postoperative recurrence and lymph node metastasis, and hence need second treatments. However, the molecular biological processes underlying this phenomenon are not understood. Therefore, we collected data on miRNA expression and clinical information of male TC patients from The Cancer Genome Atlas (TCGA) database. Differentially expressed miRNAs were identified between male TC tissues and matched normal tissues. The Kaplan–Meier method, univariate and multivariate Cox regressions, and receiver operating characteristic curve analyses were performed to assess the association between miRNAs and the disease-free survival of male TC patients. Gene Ontology (GO) and the Kyoto Encyclopaedia of Gene and Genome (KEGG) enrichment analyses were then used to explore the function of miRNA target genes. Furthermore, we evaluated the ability of the miRNA biomarker to predict survival in female TC patients. As a result, a total of 118 differentially expressed miRNAs were identified, including 25 upregulated and 93 downregulated miRNAs. Among them, miR-451a and miR-16-1-3p were confirmed to be independent prognostic factors for the disease-free survival rate. The target genes of miR-451a and miR-16-1-3p were identified, and functional analysis showed that these genes were enriched in 25 Go and KEGG accessions, including cell signal transduction, motor adhesion, phagocytosis, regulation of transcription, cell proliferation, angiogenesis, etc. Neither miR-451a and miR-16-1-3p, nor a prediction model based on both miRNAs effectively predicted survival in female TC patients. In conclusion, both miR-451a and miR-16-1-3p may play important roles in the processes of male TC. The two-miRNA signature involving miR-1258 and miR-193a may serve as a novel prognostic biomarker for male TC patients.
format Online
Article
Text
id pubmed-8439266
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-84392662021-09-29 A two-microRNA signature predicts the progression of male thyroid cancer Liu, Bingyang Shi, Haihong Qiu, Weigang Wu, Xinquan Li, Liqiong Wu, Wenyi Open Life Sci Research Article In various cancers, microRNAs (miRNAs) are abnormally expressed, including thyroid cancer (TC). In recent years, the incidence of TC has increased annually around the world. Compared with female patients, male TC patients are more likely to have a postoperative recurrence and lymph node metastasis, and hence need second treatments. However, the molecular biological processes underlying this phenomenon are not understood. Therefore, we collected data on miRNA expression and clinical information of male TC patients from The Cancer Genome Atlas (TCGA) database. Differentially expressed miRNAs were identified between male TC tissues and matched normal tissues. The Kaplan–Meier method, univariate and multivariate Cox regressions, and receiver operating characteristic curve analyses were performed to assess the association between miRNAs and the disease-free survival of male TC patients. Gene Ontology (GO) and the Kyoto Encyclopaedia of Gene and Genome (KEGG) enrichment analyses were then used to explore the function of miRNA target genes. Furthermore, we evaluated the ability of the miRNA biomarker to predict survival in female TC patients. As a result, a total of 118 differentially expressed miRNAs were identified, including 25 upregulated and 93 downregulated miRNAs. Among them, miR-451a and miR-16-1-3p were confirmed to be independent prognostic factors for the disease-free survival rate. The target genes of miR-451a and miR-16-1-3p were identified, and functional analysis showed that these genes were enriched in 25 Go and KEGG accessions, including cell signal transduction, motor adhesion, phagocytosis, regulation of transcription, cell proliferation, angiogenesis, etc. Neither miR-451a and miR-16-1-3p, nor a prediction model based on both miRNAs effectively predicted survival in female TC patients. In conclusion, both miR-451a and miR-16-1-3p may play important roles in the processes of male TC. The two-miRNA signature involving miR-1258 and miR-193a may serve as a novel prognostic biomarker for male TC patients. De Gruyter 2021-09-13 /pmc/articles/PMC8439266/ /pubmed/34595349 http://dx.doi.org/10.1515/biol-2021-0099 Text en © 2021 Bingyang Liu et al., published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
Liu, Bingyang
Shi, Haihong
Qiu, Weigang
Wu, Xinquan
Li, Liqiong
Wu, Wenyi
A two-microRNA signature predicts the progression of male thyroid cancer
title A two-microRNA signature predicts the progression of male thyroid cancer
title_full A two-microRNA signature predicts the progression of male thyroid cancer
title_fullStr A two-microRNA signature predicts the progression of male thyroid cancer
title_full_unstemmed A two-microRNA signature predicts the progression of male thyroid cancer
title_short A two-microRNA signature predicts the progression of male thyroid cancer
title_sort two-microrna signature predicts the progression of male thyroid cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439266/
https://www.ncbi.nlm.nih.gov/pubmed/34595349
http://dx.doi.org/10.1515/biol-2021-0099
work_keys_str_mv AT liubingyang atwomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT shihaihong atwomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT qiuweigang atwomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT wuxinquan atwomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT liliqiong atwomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT wuwenyi atwomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT liubingyang twomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT shihaihong twomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT qiuweigang twomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT wuxinquan twomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT liliqiong twomicrornasignaturepredictstheprogressionofmalethyroidcancer
AT wuwenyi twomicrornasignaturepredictstheprogressionofmalethyroidcancer